company background image
1110 logo

Kingworld Medicines Group SEHK:1110 株式レポート

最終価格

HK$0.43

時価総額

HK$263.9m

7D

4.9%

1Y

-44.2%

更新

21 Nov, 2024

データ

会社財務

Kingworld Medicines Group Limited

SEHK:1110 株式レポート

時価総額:HK$263.9m

1110 株式概要

投資持株会社であるキングワールド メディシンズ グループ リミテッドは、主にブランド輸入医薬品およびヘルスケア製品の流通・販売を行っている。 詳細

1110 ファンダメンタル分析
スノーフレーク・スコア
評価2/6
将来の成長0/6
過去の実績2/6
財務の健全性5/6
配当金4/6

Kingworld Medicines Group Limited 競合他社

価格と性能

の歴代最高値、変動、値下がりまとめKingworld Medicines Group
過去の株価
現在の株価HK$0.43
52週高値HK$0.77
52週安値HK$0.40
ベータ0.76
11ヶ月の変化-17.31%
3ヶ月変化-15.69%
1年変化-44.16%
33年間の変化-44.16%
5年間の変化-51.14%
IPOからの変化-79.02%

最新ニュース

The Returns On Capital At Kingworld Medicines Group (HKG:1110) Don't Inspire Confidence

Nov 13
The Returns On Capital At Kingworld Medicines Group (HKG:1110) Don't Inspire Confidence

Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt

Oct 04
Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt

Recent updates

The Returns On Capital At Kingworld Medicines Group (HKG:1110) Don't Inspire Confidence

Nov 13
The Returns On Capital At Kingworld Medicines Group (HKG:1110) Don't Inspire Confidence

Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt

Oct 04
Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0338

May 31
Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0338

Even With A 26% Surge, Cautious Investors Are Not Rewarding Kingworld Medicines Group Limited's (HKG:1110) Performance Completely

May 22
Even With A 26% Surge, Cautious Investors Are Not Rewarding Kingworld Medicines Group Limited's (HKG:1110) Performance Completely

Investors Shouldn't Be Too Comfortable With Kingworld Medicines Group's (HKG:1110) Earnings

Apr 29
Investors Shouldn't Be Too Comfortable With Kingworld Medicines Group's (HKG:1110) Earnings

Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0338

Apr 23
Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0338

A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

Mar 22
A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising

Nov 30
The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising

Slowing Rates Of Return At Kingworld Medicines Group (HKG:1110) Leave Little Room For Excitement

Aug 17
Slowing Rates Of Return At Kingworld Medicines Group (HKG:1110) Leave Little Room For Excitement

Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247

May 30
Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247

The Returns At Kingworld Medicines Group (HKG:1110) Aren't Growing

May 11
The Returns At Kingworld Medicines Group (HKG:1110) Aren't Growing

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0247

Apr 03
Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0247

Returns On Capital At Kingworld Medicines Group (HKG:1110) Paint A Concerning Picture

Feb 07
Returns On Capital At Kingworld Medicines Group (HKG:1110) Paint A Concerning Picture

A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

Oct 07
A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

Kingworld Medicines Group's (HKG:1110) Returns On Capital Not Reflecting Well On The Business

Jul 05
Kingworld Medicines Group's (HKG:1110) Returns On Capital Not Reflecting Well On The Business

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To HK$0.024

Apr 27
Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To HK$0.024

We Like These Underlying Return On Capital Trends At Kingworld Medicines Group (HKG:1110)

Aug 17
We Like These Underlying Return On Capital Trends At Kingworld Medicines Group (HKG:1110)

Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly

Apr 24
Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly

Returns On Capital Are Showing Encouraging Signs At Kingworld Medicines Group (HKG:1110)

Mar 29
Returns On Capital Are Showing Encouraging Signs At Kingworld Medicines Group (HKG:1110)

Kingworld Medicines Group's (HKG:1110) Shareholders Are Down 46% On Their Shares

Mar 08
Kingworld Medicines Group's (HKG:1110) Shareholders Are Down 46% On Their Shares

Are Insiders Buying Kingworld Medicines Group Limited (HKG:1110) Stock?

Feb 15
Are Insiders Buying Kingworld Medicines Group Limited (HKG:1110) Stock?

Should You Or Shouldn't You: A Dividend Analysis on Kingworld Medicines Group Limited (HKG:1110)

Jan 25
Should You Or Shouldn't You: A Dividend Analysis on Kingworld Medicines Group Limited (HKG:1110)

Will the Promising Trends At Kingworld Medicines Group (HKG:1110) Continue?

Dec 18
Will the Promising Trends At Kingworld Medicines Group (HKG:1110) Continue?

We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt

Dec 05
We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt

What We Learned About Kingworld Medicines Group's (HKG:1110) CEO Compensation

Nov 22
What We Learned About Kingworld Medicines Group's (HKG:1110) CEO Compensation

株主還元

1110HK HealthcareHK 市場
7D4.9%-0.6%0.4%
1Y-44.2%-23.3%12.0%

業界別リターン: 1110過去 1 年間で-23.3 % の収益を上げたHong Kong Healthcare業界を下回りました。

リターン対市場: 1110は、過去 1 年間で12 % のリターンを上げたHong Kong市場を下回りました。

価格変動

Is 1110's price volatile compared to industry and market?
1110 volatility
1110 Average Weekly Movement5.5%
Healthcare Industry Average Movement8.2%
Market Average Movement8.9%
10% most volatile stocks in HK Market18.9%
10% least volatile stocks in HK Market4.3%

安定した株価: 1110過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: 1110の 週次ボラティリティ ( 6% ) は過去 1 年間安定しています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
1996927Li Sheng Zhaowww.kingworld.com.cn

投資持株会社であるキングワールド・メディシンズ・グループ・リミテッドは、主にブランド輸入医薬品とヘルスケア製品の流通・販売に従事している。同社は、咳止め、痰の緩和、喘息の鎮静、呼吸器系の強化、消化促進、腸の健康促進、血液循環の活性化、痛みの緩和、インフルエンザ対策などの製品を、「Nin Jiom Chuan Bei Pei Pa Koa」、「Taiko Seirogan」、「Kingworld Imada Red Flower Oil」、「Culturelle probiotics product series」、「Lifeline Care product serices」、「Mentholatum product series」のブランドで提供している。また、電気治療器、理学治療器、一般検査機器の製造・販売、医薬品、ヘルスケア、一般食品、医療用品の供給も行っている。さらに、美術品の流通・販売、美術展の開催、漢方薬の流通・販売、技術移転や不動産投資活動も行っている。中華人民共和国、日本、米国、カナダ、香港、台湾、タイ、英国、ドイツ、イタリア、スペイン、メキシコ、および国際的にサービスを提供している。同社は1996年に設立され、中華人民共和国の深センに本社を置いている。

Kingworld Medicines Group Limited 基礎のまとめ

Kingworld Medicines Group の収益と売上を時価総額と比較するとどうか。
1110 基礎統計学
時価総額HK$263.93m
収益(TTM)HK$33.41m
売上高(TTM)HK$1.13b

7.6x

PER(株価収益率

0.2x

P/Sレシオ

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
1110 損益計算書(TTM)
収益CN¥1.05b
売上原価CN¥788.49m
売上総利益CN¥263.24m
その他の費用CN¥232.15m
収益CN¥31.09m

直近の収益報告

Jun 30, 2024

次回決算日

該当なし

一株当たり利益(EPS)0.052
グロス・マージン25.03%
純利益率2.96%
有利子負債/自己資本比率49.6%

1110 の長期的なパフォーマンスは?

過去の実績と比較を見る

配当金

7.6%

現在の配当利回り

58%

配当性向